Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines (Q71801217)
Jump to navigation
Jump to search
scientific article published on 01 December 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines |
scientific article published on 01 December 1994 |
Statements
Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokines (English)
Abbs IC
Clark M
Chatenoud L
1 December 1994